Our Extended Family of Portfolio Companies

Investing in transformational ideas and entrepreneurial grit to solve major unmet needs in patient care

view more →

Bivarus is a healthcare IT company that has developed an elegant and efficient patient survey platform. Acquired by Press Ganey Associates in January 2018.

view more →

Boston Immune Technologies & Therapeutics is a clinical-stage biotechnology company developing a novel class of antagonist antibodies

view more →

Developer of a technology designed to extract highly sensitive nucleic acid quantification. Acquired by Bio-Rad 2021

view more →

Elligo Health Research is a healthcare-enabling research organization that integrates clinical trials directly into routine patient care

view more →

Kymera Therapeutics, Inc. is a clinical-stage biotechnology company pioneering targeted protein degradation. IPO in August 2020 (NASDAQ: KYMR).

view more →

Provider of patient experience platform designed to facilitate the relationship between physicians and patients. Acquired by NextGen 2019

view more →

Developer of staffing, communication and schedule management tools designed to modernize staffing processes. Acquired by HealthStream 2020

view more →

Perfuse Therapeutics is a clinical-stage biopharmaceutical company developing first-in-class therapies to improve retinal blood flow and treat ischemia-driven eye diseases.

view more →

Developer of a molecular diagnostics technology designed to dramatically reduce time to results in microbiology.

view more →

Qpex Biopharma is a clinical-stage biopharmaceutical company developing novel anti-infective therapies. Acquired by Shionogi 2023

view more →

Ribometrix is a biotechnology company pioneering a new class of small-molecule therapeutics that directly target the three-dimensional structures of RNA to modulate disease biology.

view more →

Rodin Therapeutics was a biotechnology company focused on discovering and developing first-in-class small molecule therapeutics. Acquired by ALKS in Nov 2019

view more →

Standard Bariatrics is a medical device company focused on advancing bariatric surgery.

view more →

Stridebio is developing engineered viral vectors for gene therapy. Acquired by Ginkgo Bioworks 2023

view more →

Trefoil Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to restore vision for people with corneal diseases.

“It is not the critic who counts: not the man who points out how the strong man stumbles or where the doer of deeds could have done better. The credit belongs to the man who is actually in the arena, whose face is marred by dust and sweat and blood, who strives valiantly, who errs and comes up short again and again, because there is no effort without error or shortcoming, but who knows the great enthusiasms, the great devotions, who spends himself in a worthy cause; who, at the best, knows, in the end, the triumph of high achievement, and who, at the worst, if he fails, at least he fails while daring greatly, so that his place shall never be with those cold and timid souls who knew neither victory nor defeat.”


Theodore Roosevelt
Speech at the Sorbonne, Paris, April 23, 1910